Onco Wiki / Regimen

Dostarlimab + carbo + paclitaxel (endometrial advanced 1L dMMR)

Deterministic view of the source YAML entity. Clinical authority remains with the cited source IDs and reviewer sign-off state.

Knowledge-base record for audit. Provisional clinical content: this is not a prescription. An oncologist must verify original sources, applicability and review status. Full rules and constraints are in the YAML.

Source YAML: complete record

ComponentsDRUG-DOSTARLIMAB DRUG-CARBOPLATIN DRUG-PACLITAXEL
IDREG-DOSTARLIMAB-CARBO-PACLI-ENDOM
TypeRegimen
Statuspending_clinical_signoff
DiseasesNone declared
SourcesSRC-ESMO-ENDOMETRIAL-2022 SRC-NCCN-UTERINE-2025

Notes

RUBY: dostarlimab+chemo PFS HR 0.30 dMMR, 0.64 pMMR.

Used By

Indication